Enterprise Therapeutics is a drug discovery company dedicated to the research
and development of novel therapies for the treatment of respiratory diseases.

In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.


Enterprise Therapeutics will be attending:

> European Cystic Fibrosis Conference – 07 – 10 June 2017 Seville, Spain.

> Cystic Fibrosis Foundation Research Conference, Pushing the Frontiers – 18 – 21 June 2017 Skamania Lodge, Stevenson, WA, USA.

LinkedIn BIA Member Logo